Literature DB >> 16469808

Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors.

Gregory M Sutton1, James L Trevaskis, Matthew W Hulver, Ryan P McMillan, Nathan J Markward, M Josephine Babin, Emily A Meyer, Andrew A Butler.   

Abstract

Loss of brain melanocortin receptors (Mc3rKO and Mc4rKO) causes increased adiposity and exacerbates diet-induced obesity (DIO). Little is known about how Mc3r or Mc4r genotype, diet, and obesity affect insulin sensitivity. Insulin resistance, assessed by insulin and glucose tolerance tests, Ser(307) phosphorylation of insulin receptor substrate 1, and activation of protein kinase B, was examined in control and DIO wild-type (WT), Mc3rKO and Mc4rKO C57BL/6J mice. Mc4rKO mice were hyperphagic and had increased metabolic efficiency (weight gain per kilojoule consumed) relative to WT; both parameters increased further on high-fat diet. Obesity of Mc3rKO was more dependent on fat intake, involving increased metabolic efficiency. Fat mass of DIO Mc3rKO and Mc4rKO was similar, although Mc4rKO gained weight more rapidly. Mc4rKO develop hepatic insulin resistance and severe hepatic steatosis with obesity, independent of diet. DIO caused further deterioration of insulin action in Mc4rKO of either sex and, in male Mc3rKO, compared with controls, associated with increased fasting insulin, severe glucose intolerance, and reduced insulin signaling in muscle and adipose tissue. DIO female Mc3rKO exhibited very modest perturbations in glucose metabolism and insulin sensitivity. Consistent with previous data suggesting impaired fat oxidation, both Mc3rKO and Mc4rKO had reduced muscle oxidative metabolism, a risk factor for weight gain and insulin resistance. Energy expenditure was, however, increased in Mc4rKO compared with Mc3rKO and controls, perhaps due to hyperphagia and metabolic costs associated with rapid growth. In summary, DIO affects insulin sensitivity more severely in Mc4rKO compared with Mc3rKO, perhaps due to a more positive energy balance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469808      PMCID: PMC2735103          DOI: 10.1210/en.2005-1209

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  66 in total

1.  Agouti-related peptide-expressing neurons are mandatory for feeding.

Authors:  Eva Gropp; Marya Shanabrough; Erzsebet Borok; Allison W Xu; Ruth Janoschek; Thorsten Buch; Leona Plum; Nina Balthasar; Brigitte Hampel; Ari Waisman; Gregory S Barsh; Tamas L Horvath; Jens C Brüning
Journal:  Nat Neurosci       Date:  2005-09-11       Impact factor: 24.884

2.  Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and food intake.

Authors:  James L Trevaskis; Andrew A Butler
Journal:  Endocrinology       Date:  2005-06-30       Impact factor: 4.736

3.  Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues.

Authors:  D J Marsh; G I Miura; K A Yagaloff; M W Schwartz; G S Barsh; R D Palmiter
Journal:  Brain Res       Date:  1999-11-27       Impact factor: 3.252

4.  Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans.

Authors:  Matthew W Hulver; Jason R Berggren; Michael J Carper; Makoto Miyazaki; James M Ntambi; Eric P Hoffman; John P Thyfault; Robert Stevens; G Lynis Dohm; Joseph A Houmard; Deborah M Muoio
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

5.  Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype.

Authors:  Gavin A Bewick; James V Gardiner; Waljit S Dhillo; Aysha S Kent; Nicholas E White; Zoe Webster; Mohammad A Ghatei; Stephen R Bloom
Journal:  FASEB J       Date:  2005-08-11       Impact factor: 5.191

Review 6.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 7.  Mechanisms of insulin resistance in humans and possible links with inflammation.

Authors:  David B Savage; Kitt F Petersen; Gerald I Shulman
Journal:  Hypertension       Date:  2005-04-11       Impact factor: 10.190

8.  Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity.

Authors:  Ningping Feng; Sharla F Young; Greti Aguilera; Elena Puricelli; Diane C Adler-Wailes; Nancy G Sebring; Jack A Yanovski
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

9.  Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin.

Authors:  Yubin Zhang; Gail E Kilroy; Tara M Henagan; Vera Prpic-Uhing; William G Richards; Anthony W Bannon; Randall L Mynatt; Thomas W Gettys
Journal:  FASEB J       Date:  2005-09       Impact factor: 5.191

10.  A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle.

Authors:  Lauren M Sparks; Hui Xie; Robert A Koza; Randall Mynatt; Matthew W Hulver; George A Bray; Steven R Smith
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

View more
  80 in total

1.  Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells.

Authors:  Jodi F Evans; Anne Fernando; Louis Ragolia
Journal:  Mol Cell Endocrinol       Date:  2012-01-27       Impact factor: 4.102

2.  Adropin deficiency is associated with increased adiposity and insulin resistance.

Authors:  K Ganesh Kumar; Jingying Zhang; Su Gao; Jari Rossi; Owen P McGuinness; Heather H Halem; Michael D Culler; Randall L Mynatt; Andrew A Butler
Journal:  Obesity (Silver Spring)       Date:  2012-02-09       Impact factor: 5.002

Review 3.  Homeostastic and non-homeostatic functions of melanocortin-3 receptors in the control of energy balance and metabolism.

Authors:  Karima Begriche; Gregory M Sutton; Andrew A Butler
Journal:  Physiol Behav       Date:  2011-04-13

Review 4.  Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problems.

Authors:  Minying Cai; Joel Nyberg; Victor J Hruby
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

5.  Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle.

Authors:  Gregory M Sutton; Karima Begriche; K Ganesh Kumar; Jeffrey M Gimble; Diego Perez-Tilve; Ruben Nogueiras; Ryan P McMillan; Matthew W Hulver; Matthias H Tschöp; Andrew A Butler
Journal:  FASEB J       Date:  2009-10-16       Impact factor: 5.191

6.  Abnormal glucose metabolism in hypertensive mice with genetically interrupted gamma-melanocyte stimulating hormone signaling fed a high-sodium diet.

Authors:  X-P Ni; Michael H Humphreys
Journal:  Am J Hypertens       Date:  2008-09-18       Impact factor: 2.689

Review 7.  Central nervous system control of metabolism.

Authors:  Martin G Myers; David P Olson
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

Review 8.  A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes.

Authors:  Andrew A Butler; Leslie P Kozak
Journal:  Diabetes       Date:  2010-02       Impact factor: 9.461

9.  Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitus.

Authors:  Kaiying Guo; Yi-Hao Yu; Jue Hou; Yiying Zhang
Journal:  Nutr Metab (Lond)       Date:  2010-07-12       Impact factor: 4.169

10.  Differential body weight, blood pressure and placental inflammatory responses to normal versus high-fat diet in melanocortin-4 receptor-deficient pregnant rats.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.